Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Arsenic as an endocrine disruptor: effects of arsenic on estrogen receptor-mediated gene expression in vivo and in cell culture.

Davey JC, Bodwell JE, Gosse JA, Hamilton JW.

Toxicol Sci. 2007 Jul;98(1):75-86. Epub 2007 Feb 5.

PMID:
17283378
2.

Arsenic as an endocrine disruptor: arsenic disrupts retinoic acid receptor-and thyroid hormone receptor-mediated gene regulation and thyroid hormone-mediated amphibian tail metamorphosis.

Davey JC, Nomikos AP, Wungjiranirun M, Sherman JR, Ingram L, Batki C, Lariviere JP, Hamilton JW.

Environ Health Perspect. 2008 Feb;116(2):165-72. doi: 10.1289/ehp.10131.

4.

17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.

Zheng J, Kulp SK, Zhang Y, Sugimoto Y, Dayton MA, Govindan MV, Brueggemeier RW, Lin YC.

Anticancer Res. 2000 Jan-Feb;20(1A):11-9.

PMID:
10769629
6.

Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol.

Ramamoorthy K, Vyhlidal C, Wang F, Chen I, Safe S, McDonnell DP, Leonard LS, Gaido KW.

Toxicol Appl Pharmacol. 1997 Nov;147(1):93-100.

PMID:
9356311
8.
9.
10.

Selective activation of zebrafish estrogen receptor subtypes by chemicals by using stable reporter gene assay developed in a zebrafish liver cell line.

Cosnefroy A, Brion F, Maillot-Maréchal E, Porcher JM, Pakdel F, Balaguer P, Aït-Aïssa S.

Toxicol Sci. 2012 Feb;125(2):439-49. doi: 10.1093/toxsci/kfr297. Epub 2011 Nov 1.

PMID:
22045033
11.

Development of a stably transfected estrogen receptor-mediated luciferase reporter gene assay in the human T47D breast cancer cell line.

Legler J, van den Brink CE, Brouwer A, Murk AJ, van der Saag PT, Vethaak AD, van der Burg B.

Toxicol Sci. 1999 Mar;48(1):55-66.

PMID:
10330684
13.

Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo.

Evans MJ, Eckert A, Lai K, Adelman SJ, Harnish DC.

Circ Res. 2001 Oct 26;89(9):823-30.

14.

Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors.

Yoshida T, Eguchi H, Nakachi K, Tanimoto K, Higashi Y, Suemasu K, Iino Y, Morishita Y, Hayashi S.

Carcinogenesis. 2000 Dec;21(12):2193-201.

PMID:
11133808
17.

A novel antiestrogenic mechanism in progesterone receptor-transfected breast cancer cells.

Zheng ZY, Bay BH, Aw SE, Lin VC.

J Biol Chem. 2005 Apr 29;280(17):17480-7. Epub 2005 Feb 22.

19.
20.

Supplemental Content

Support Center